Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Equity (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Return on Equity data on record, last reported at 0.15% in Q3 2025.

  • For Q3 2025, Return on Equity fell 6.0% year-over-year to 0.15%; the TTM value through Sep 2025 reached 0.15%, down 6.0%, while the annual FY2024 figure was 0.24%, 1.0% up from the prior year.
  • Return on Equity reached 0.15% in Q3 2025 per AMPH's latest filing, down from 0.19% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.25% in Q3 2023 and bottomed at 0.0% in Q1 2021.
  • Average Return on Equity over 5 years is 0.17%, with a median of 0.2% recorded in 2023.
  • Peak YoY movement for Return on Equity: dropped -18bps in 2021, then increased 18bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.15% in 2021, then soared by 38bps to 0.2% in 2022, then grew by 10bps to 0.22% in 2023, then increased by 3bps to 0.23% in 2024, then tumbled by -33bps to 0.15% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.15% in Q3 2025, 0.19% in Q2 2025, and 0.2% in Q1 2025.